Egis Gyogyszergyar Rt.

Gis Gyogyszergyar Rt.

Edit Horvath

Imre Moravcsik

Istvan Gyertyan

Ferenc Andrasi

Tamas Hamori

Pal Berzsenyi

Jozsef Reiter

Gabor Zolyomi

Pal Vago

Eszter Szentkuti

Katalin Horvath

Anna Bakonyi

Gyorgyne Mate

Gyula Simig

Gabor Gigler

Istvan Gacsalyi

Gabor Blasko

Andras Egyed

Gyorgy Somogyi

Andras Bilkei-Gorzo

Karoly Tihanyi

Judit Bajnogel

Erszebet Birkas

Peter Botka, Deceased

Jeno Korosi, Deceased

Cecilia Salamon Haskane

Peter Korosi

Hilda Botka

Klara Daroczi Kazone

The invention relates to new 1-[2-(substituted vinyl)]-3,4-dihydro-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof and pharmaceutical compositions comprising them. The new 1-[2-(substituted vinyl)]-3,4-dihidro-5H-2,3-benzodiazepine derivatives according to the invention correspond to the general formula (I), ##STR1## wherein the variables are hereinbelow defined: The new compounds according to the invention affect the central nervous system and can be used to advantage in the therapy.

1-[2-(substituted vinyl)]-3,4-dihydro-4-dihydro-5H-2,3-benzodiazepine

This invention relates to new 1-�2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives, a process for the preparation thereof, pharmaceutical compositions comprising the same, to the use of the said benzodiazepine derivatives for the treatment of diseases and for the preparation of pharmaceutical compositions suitable for the treatment of diseases. The compounds according to the invention correspond to the general formula (I), ##STR1## wherein the variables are herein below defined, and the compounds possess central nervous activities.

1-�2-(substituted vinyl)!-5H-2,3-benzodiazepine derivatives

Growing community of inventors

Budapest, Hungary

Edit Horvath